AMANDA VLASVELD: Open Payments
NPI 1952670606 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$297 in 15 payments from 8 companies in 2025. Trend: 2023 $377 · 2024 $234 · 2025 $297
Food & beverage: $297
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 4 | $96 |
| Sumitomo Pharma America, Inc. | 3 | $66 |
| SHIELD THERAPEUTICS INC | 2 | $38 |
| ABBVIE INC. | 1 | $24 |
| Hologic Sales and Service, LLC | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| CooperSurgical, Inc. | 1 | $17 |
| Evofem Biosciences, Inc. | 2 | $13 |
Products named: ZURZUVAE, MYFEMBREE, ACCRUFER, ORILISSA, GEMTESA, APTIMA, Qelbree, Paragard T 380A.
Industry payments across CA — which companies pay providers there.
